Difficulty: Medium
Average Score: 77%
Practice
A 55-year-old woman is noted to be taking tamoxifen to help with breast cancer. She also complains of vaginal bleeding. She asks why she is having vaginal bleeding. Which of the following is the best explanation?
Correct answer
C
Rationale
Tamoxifen (choice C), a SERM, acts as an estrogen antagonist in breast tissue, inhibiting cancer growth, but as an agonist in the uterus, stimulating endometrial proliferation, which can cause vaginal bleeding due to hyperplasia. Choice A incorrectly suggests agonism in the breast, choice B misstates uterine antagonism, and choice D ignores its uterine effect. This tissue-selective action explains the bleeding, a known side effect requiring monitoring, as it increases endometrial cancer risk. Understanding tamoxifen's dual role is critical for managing breast cancer patients, balancing therapeutic benefits against uterine complications.